According to Pulmonary Hypertension News, a study shows that a 6-month warfarin treatment may not be sufficient for patients with pulmonary embolism complicated by obstructive sleep apnea hypopnea syndrome.

The goal of the study was to assess whether routine warfarin treatment for 6 months would be effective enough in individuals with pulmonary embolism aggravated by OSAHS. The team analyzed 97 patients with pulmonary embolism, from whom 32 had OSAHS. Warfarin treatment was administered for 6 months and all the patients were followed-up for 18 months.

Get the full story at